Upside case
Bull case
$65+47.2%
BN would need investors to value it at roughly 24x earnings — about 8x more generous than today's 16x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Analysis OverviewBuyUpdated Jun 18, 2026
Brookfield Corporation (BN) Stock Analysis
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Analyst consensus
Buy
Covering
9
analysts
8 bullish · 0 bearish · 9 covering BN
Strong Buy
0
Buy
8
Hold
1
Sell
0
Strong Sell
0
Consensus Target
$59
+32.2% vs today
Scenario Range
$31 – $65
Model bear to bull value window
Coverage
9
Published analyst ratings
Valuation Context
16.1x
Forward P/E · Market cap $99.4B
BN price targets
Three scenarios for where BN stock could go
Current
~$44
Confidence
49 / 100
Updated
Jun 18, 2026
Where we are now
Current · $44
Bear
$31
Base
$50
Bull
$65
Market caseClosest to today
Base case
$50+11.7%
This is close to how the market is already pricing BN — at roughly 18x forward earnings. No dramatic re-rating needed, just steady execution on the core business.
Stress case
Bear case
$31-29.6%
If investor confidence fades or macro conditions deteriorate, a 5x multiple contraction could push BN down roughly 30% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.
Brookfield Corporation
BN · NYSEFinancial ServicesAsset ManagementDecember year-end
Brookfield Corporation is a global alternative asset manager that invests in and operates premier real estate, renewable power, infrastructure, and private equity assets. It generates revenue primarily through asset management fees from its vast investment funds — roughly 60% of earnings — and carried interest from investment performance, supplemented by direct investment income from its own substantial balance sheet. The company's key competitive advantage lies in its massive scale, deep operational expertise across complex asset classes, and ability to deploy large-scale capital into infrastructure-like investments that few competitors can match.
Market Cap
$99.4B
Revenue TTM
$76.6B
Net Income TTM
$1.3B
Net Margin
1.7%
BN Revenue and Earnings Performance
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
EPS Beat Rate
100%Exceptional
12 quarters tracked
Revenue Beat Rate
91%Exceptional
vs consensus estimates
Avg EPS Surprise
+19.8%
above Street consensus
Beat / Miss Record
BeatMissLeft = EPS · Right = Revenue
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Last 4 Quarters
EPS beats: 4 of 4Q3 2025
EPS
$0.88/$0.59
Revenue
$1.5B/$1.4B
Q4 2025
EPS
$0.63/$0.59
Revenue
$18.9B/$11.8B
Q1 2026
EPS
$0.67/$0.61
Revenue
$1.7B/$1.6B
Q2 2026
EPS
$0.66/$0.60
Revenue
$1.6B/$1.6B
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $0.88/$0.59 | +48.4% | $1.5B/$1.4B | +2.8% |
| Q4 2025 | $0.63/$0.59 | +6.2% | $18.9B/$11.8B | +60.7% |
| Q1 2026 | $0.67/$0.61 | +9.8% | $1.7B/$1.6B | +5.0% |
| Q2 2026 | $0.66/$0.60 | +9.6% | $1.6B/$1.6B | +0.8% |
FY1–FY2 Estimates
Revenue Outlook
FY1
$75.2B
-1.9% YoY
FY2
$76.6B
+1.9% YoY
EPS Outlook
FY1
$0.86
+52.5% YoY
FY2
$1.38
+60.4% YoY
Trailing FCF (TTM)-$7.3B
FCF Margin: -9.5%
Next Earnings
August 6, 2026
Expected EPS
$0.65
Expected Revenue
$1.6B
BN beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
BN Revenue Breakdown by Segment
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest disclosure
FY 2025
Total disclosed revenue $68.1B
Product Mix
Latest annual revenue by segment or product family
Segment breakdown not available for this company.
Geographic Mix
Latest annual revenue by reported region
UNITED STATES
40.2%
+4.7% YoY
Tap, hover, or focus a slice to inspect segment detail.
UNITED STATES is the largest reported region at 40.2%, up 4.7% YoY.
BN Valuation Snapshot
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Relative Value Signal
Cheap versus peers
Fair value est. $75 — implies +67.8% from today's price.
Upside to Fair Value
67.8%
potential upside
Deep DiscountFair ValueVery Expensive
vs S&P 500 Trailing P/E
BN
88.9x
vs
S&P 500
24.4x
+264% premium
vs Financial Services Trailing P/E
BN
88.9x
vs
Financial Services
13.6x
+554% premium
vs BN 5Y Avg P/E
Today
88.9x
vs
5Y Average
78.0x
+14% premium
Forward PE
16.1x
S&P 500
18.8x
-14%
Financial Services
10.7x
+51%
5Y Avg
—
—
Trailing PE
88.9x
S&P 500
24.4x
+264%
Financial Services
13.6x
+554%
5Y Avg
78.0x
+14%
PEG Ratio
—
S&P 500
1.66x
—
Financial Services
0.95x
—
5Y Avg
—
—
EV/EBITDA
12.3x
S&P 500
15.2x
-19%
Financial Services
11.4x
+8%
5Y Avg
12.2x
+1%
Price/FCF
—
S&P 500
20.7x
—
Financial Services
11.1x
—
5Y Avg
57.0x
—
Price/Sales
1.3x
S&P 500
3.1x
-58%
Financial Services
2.3x
-44%
5Y Avg
0.9x
+38%
Dividend Yield
—
S&P 500
1.91%
—
Financial Services
2.63%
—
5Y Avg
—
—
| Metric | BN | S&P 500 | Financial Services | 5Y Avg BN |
|---|---|---|---|---|
| Forward PE | 16.1x | 18.8x-14% | 10.7x+51% | — |
| Trailing PE | 88.9x | 24.4x+264% | 13.6x+554% | 78.0x+14% |
| PEG Ratio | — | 1.66x | 0.95x | — |
| EV/EBITDA | 12.3x | 15.2x-19% | 11.4x | 12.2x |
| Price/FCF | — | 20.7x | 11.1x | 57.0x |
| Price/Sales | 1.3x | 3.1x-58% | 2.3x-44% | 0.9x+38% |
| Dividend Yield | — | 1.91% | 2.63% | — |
BN trades above S&P 500 benchmarks on 1 of 4 measured multiples — appears modestly priced relative to the S&P 500 on most measures.
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolBN Financial Health
Verdict
Adequate
BN generates 0.8% ROE and 0.3% return on assets — the two primary signals for banking profitability. FCF-based metrics are not applicable to financial companies.
Earnings Engine
Revenue, profitability, and return on capital
Revenue (TTM)
Trailing-twelve-month sales base
$76.6B
Revenue Growth
TTM vs prior year
—
Operating Margin
Operating income divided by revenue
28.3%
Net Margin
Net income divided by revenue
1.7%
EPS (TTM)
Diluted earnings per share, trailing twelve months
$0.56
ROE
Return on equity — the primary profitability signal for banks
0.8%
Capital Quality
ROIC, leverage, and debt serviceability
ROIC
Return on invested capital — primary competitive quality signal
3.7%
ROA
Return on assets, trailing twelve months
0.3%
Cash & Equivalents
Liquid assets on the balance sheet
$16.2B
Net Debt
Total debt minus cash
$296.4B
FCF Analysis
Traditional FCF and debt/FCF ratios are not meaningful for financial companies. Focus on ROE and ROA above.
ROE
Return on equity — the headline bank profitability metric
0.8%
Shareholder Returns
How capital is returned to owners
Total shareholder yield
0.0%
Dividend
—
Buyback
0.0%
Share Repurchases
Trailing buyback outflow — dollar magnitude of capital returned
$0
Dividend / Share
Annualized trailing dividend per share
—
Payout Ratio
Share of earnings distributed as dividends
—
Shares Outstanding
Current diluted share count
2.2B
All figures from the trailing twelve months. For financial companies, ROE and ROA are the primary health signals — FCF-based metrics are not applicable.
Open full ratios pageBN Stock Risk Factors
Key factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 11, 2026
High Risk
Valuation Discount
Brookfield trades at a discount to its NAV, potentially as high as 31%. This discount reflects negative investor sentiment and could impede near‑term valuation recovery.
High Risk
Real Estate Exposure
A 50% decline in real‑estate IFRS values has weighed on the company’s outlook, exposing it to significant market‑value erosion.
High Risk
Financial Complexity
Discrepancies between distributable earnings and GAAP net income raise credibility concerns, as GAAP accounting may obscure true profitability and contribute to the valuation discount.
Medium
Debt & Cash Flow
Brookfield reports negative free cash flow per share and a rising debt‑to‑equity ratio, increasing reliance on debt financing amid tightening credit markets.
Medium
Growth Lag
Analysts project negative forward revenue growth, suggesting BN may lag competitors in innovation and asset‑under‑management returns.
Medium
Interest Rate Sensitivity
Bond holdings are exposed to interest‑rate risk; rising rates could depress bond prices and reduce portfolio income.
Lower
Operational Metrics
ROIC below 3% and operating margins under 13% for extended periods signal potential operational inefficiencies.
Lower
Fee Growth Slowdown
A slowdown in fee‑bearing capital growth below mid‑teens guidance could halt fee growth and negatively impact the share price.
Lower
Insurance Float Returns
Reinvestment returns on insurance float falling below 5% in a high‑rate environment could erode the compounding base.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Why BN Stock Could Outperform
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 11, 2026
Diversified Real Assets & Growth Potential
Brookfield manages roughly $1 trillion in assets across renewable energy, infrastructure, private credit, real estate, and insurance/retirement solutions. The firm is actively investing in AI infrastructure, data centers, and nuclear energy, positioning itself to capture long‑term growth trends. Management projects a target of doubling fee‑related earnings by 2029.
Strong Financials & Experienced Management
Brookfield has delivered double‑digit annualized returns for decades, under CEO Bruce Flatt’s long‑term growth strategy. The company generates substantial annual distributable earnings, maintains a robust balance sheet, and produces recurring cash flow.
Strategic Wealth Solutions & Alternative Investments
Brookfield is expanding into advanced alternative investment vehicles and its Wealth Solutions business, which acquires fixed‑income annuities and redeploys capital at higher rates. Its insurance operations also provide a significant float, creating additional revenue and capital deployment opportunities.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
BN Stock Price Performance
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Current Price
$44.44
52W Range Position
56%
52-Week Range
Current price plotted between the 52-week low and high.
52-Week Low
$37.93
+17.2% from the low
52-Week High
$49.57
-10.3% from the high
1 Month
-1.38%
3 Month
+13.22%
YTD
-4.7%
1 Year
+12.1%
3Y CAGR
+26.7%
5Y CAGR
+10.9%
10Y CAGR
+13.7%
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
BN vs Peers
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
Peer Set
Accurate peer set
Forward PE
16.1x
vs 16.1x median
+0% above peer median
Revenue Growth
-1.9%
vs +12.9% median
-114% below peer median
Net Margin
1.7%
vs 12.4% median
-86% below peer median
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
BN BN Brookfield Corporation | $99.4B | 16.1x | -1.9% | 1.7% | Buy | +32.2% |
BX BX Blackstone Inc. | $97.0B | 21.0x | +13.5% | 21.8% | Buy | +26.3% |
KKR KKR KKR & Co. Inc. | $86.5B | 16.1x | -5.0% | 12.4% | Buy | +45.5% |
APO APO Apollo Global Management, Inc. | $79.3B | 15.4x | +12.1% | 7.2% | Buy | +11.6% |
CG CG The Carlyle Group Inc. | $16.2B | 11.1x | +12.9% | 13.7% | Buy | +36.2% |
ARE ARES Ares Management Corporation | $42.5B | 21.5x | +13.3% | 9.0% | Buy | +32.3% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
BN Dividend and Capital Return
BN does not currently return meaningful capital to shareholders.
Dividend UnknownFCF Unknown
Total Shareholder Yield
0.0%
Dividend + buyback return per year
Buyback Yield
0.0%
Dividend Yield
—
Payout Ratio
—
Dividend Profile
Yield, cadence, and growth quality
Dividend / Share
Trailing annualized cash dividend
$0.26
Growth Streak
Consecutive years of dividend increases
2Y
3Y Div CAGR
-7.4%
5Y Div CAGR
4.5%
Ex-Dividend Date
—
Payment Cadence
Quarterly
4 payments over the last 12 months
Buyback Engine
How much per-share support comes from repurchases
Repurchases (TTM)
Cash used for buybacks in the latest trailing period
$0
Estimated Shares Retired
0
Approx. Share Reduction
0.0%
Shares Outstanding
Current diluted share count from the screening snapshot
2.2B
| Year | Div / Share | YoY Grw |
|---|---|---|
| 2026 | $0.14 | — |
| 2025 | $0.24 | +12.5% |
| 2024 | $0.21 | +14.3% |
| 2023 | $0.19 | -38.1% |
| 2022 | $0.30 | +8.1% |
FAQ
7 questionsBN Investor Questions
Common questions answered from live analyst data and company financials.
01Is Brookfield Corporation (BN) stock a buy or sell in 2026?
Brookfield Corporation (BN) is rated Buy by Wall Street analysts as of 2026. Of 9 analysts covering the stock, 8 rate it Buy or Strong Buy, 1 rate it Hold, and 0 rate it Sell or Strong Sell. The consensus 12-month price target is $59, implying +32.2% from the current price of $44. The bear case scenario is $31 and the bull case is $65.
02What is the BN stock price target for 2026?
The Wall Street consensus price target for BN is $59 based on 9 analyst estimates. The high-end target is $61 (+37.3% from today), and the low-end target is $53 (+19.3%). The base case model target is $50.
03Is Brookfield Corporation (BN) stock overvalued in 2026?
BN trades at 16.1x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals cheap versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
04What are the main risks for Brookfield Corporation (BN) stock in 2026?
The primary risks for BN in 2026 are: (1) Valuation Discount — Brookfield trades at a discount to its NAV, potentially as high as 31%. (2) Real Estate Exposure — A 50% decline in real‑estate IFRS values has weighed on the company’s outlook, exposing it to significant market‑value erosion. (3) Financial Complexity — Discrepancies between distributable earnings and GAAP net income raise credibility concerns, as GAAP accounting may obscure true profitability and contribute to the valuation discount. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
05What is Brookfield Corporation's revenue and earnings forecast?
Analyst consensus estimates BN will report consensus revenue of $75.2B (-1.9% year-over-year) and EPS of $0.86 (+52.5% year-over-year) for the upcoming fiscal year. The following year, analysts project $76.6B in revenue.
06When does Brookfield Corporation (BN) report its next earnings?
Brookfield Corporation is expected to report its next earnings on approximately 2026-08-06. Consensus expects EPS of $0.65 and revenue of $1.6B. Over recent quarters, BN has beaten EPS estimates 100% of the time.
07How much free cash flow does Brookfield Corporation generate?
Brookfield Corporation (BN) had a free cash outflow of $7.3B in free cash flow over the trailing twelve months — a free cash flow margin of 9.5%. BN returns capital to shareholders through and share repurchases ($0 TTM).